Illicit Opioids: Office of National Drug Control Policy and Other Agencies Need to Better Assess Strategic Efforts

U.S. Government Accountability Office. 05/17/2018 This 13-page document is testimony before the House of Representatives Committee on Oversight and Government Reform to discuss the Government Accountability Office ' s recent work related to combating the opioid problem and the role of the Office of National Drug Control Policy (ONDCP). It discusses federal agencies ' specific opioid-related strategies and the extent to which each agency is measuring its performance; and their efforts to enhance collaboration and information sharing to limit the availability of illicit opioids, ongoing challenges to doing this, and ONDCP ' s role in enhancing such collaboration. (PDF)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - Category: International Medicine & Public Health Authors: Source Type: news